Evidence map›Paper›PMID 35892391›Full record

ArticleAntibiotics (Basel, Switzerland)2022

A Time Series Analysis Evaluating Antibiotic Prescription Rates in Long-Term Care during the COVID-19 Pandemic in Alberta and Ontario, Canada.

Manon R Haverkate, Derek R Macfadden, Nick Daneman, Jenine Leal, Michael Otterstatter, Roshanak Mahdavi, Adam G D'Souza, Elissa Rennert-May, Michael Silverman, Kevin L Schwartz and 4 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Manon R HaverkateFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Derek R MacfaddenOttawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1Y 4E9, Canada.
Nick DanemanICES, Toronto, ON M4N 3M5, Canada.
Jenine LealDepartment of Community Health Services and Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, and O'Brien Institute of Public Health, University of Calgary, Calgary, AB T2N 1N4, Canada.
Michael OtterstatterBritish Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
Roshanak MahdaviICES, Toronto, ON M4N 3M5, Canada.ORCID 0000-0003-1546-074X
Adam G D'SouzaCentre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0002-4270-2065
Elissa Rennert-MayDepartment of Community Health Services and Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, and O'Brien Institute of Public Health, University of Calgary, Calgary, AB T2N 1N4, Canada.
Michael SilvermanDivision of Infectious Diseases, Faculty of Medicine, University of Western Ontario, London, ON N6A 3K7, Canada.
Kevin L SchwartzICES, Toronto, ON M4N 3M5, Canada.
Andrew M MorrisSinai Health, University Health Network, and University of Toronto, Toronto, ONM5S 1A1, Canada.
Ariana SaatchiFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
David M PatrickBritish Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
Fawziah MarraFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
University of British Columbia · CAAlberta Health Services · CASunnybrook Health Science Centre · CAUniversity Health Network · CAUniversity of Ottawa · CAUniversity of Toronto · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic affected access to care, and the associated public health measures influenced the transmission of other infectious diseases. The pandemic has dramatically changed antibiotic prescribing in the community. We aimed to determine the impact of the COVID-19 pandemic and the resulting control measures on oral antibiotic prescribing in long-term care facilities (LTCFs) in Alberta and Ontario, Canada using linked administrative data. Antibiotic prescription data were collected for LTCF residents 65 years and older in Alberta and Ontario from 1 January 2017 until 31 December 2020. Weekly prescription rates per 1000 residents, stratified by age, sex, antibiotic class, and selected individual agents, were calculated. Interrupted time series analyses using SARIMA models were performed to test for changes in antibiotic prescription rates after the start of the pandemic (1 March 2020). The average annual cohort size was 18,489 for Alberta and 96,614 for Ontario. A significant decrease in overall weekly prescription rates after the start of the pandemic compared to pre-pandemic was found in Alberta, but not in Ontario. Furthermore, a significant decrease in prescription rates was observed for antibiotics mainly used to treat respiratory tract infections: amoxicillin in both provinces (Alberta: −0.6 per 1000 LTCF residents decrease in weekly prescription rate, p = 0.006; Ontario: −0.8, p < 0.001); and doxycycline (−0.2, p = 0.005) and penicillin (−0.04, p = 0.014) in Ontario. In Ontario, azithromycin was prescribed at a significantly higher rate after the start of the pandemic (0.7 per 1000 LTCF residents increase in weekly prescription rate, p = 0.011). A decrease in prescription rates for antibiotics that are largely used to treat respiratory tract infections is in keeping with the lower observed rates for respiratory infections resulting from pandemic control measures. The results should be considered in the contexts of different LTCF systems and provincial public health responses to the pandemic.

Indexed as

antibiotic prescribingCOVID-19epidemiologylong-term caretime series analysis

Identifiers

PMID35892391
PMCPMC9330385
OpenAlexW4288041851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.